FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to pharmaceutics and medicine, specifically to a kit for preparing an injection solution having anticancer activity, consisting of 5% glucose solution for injections and powder of active pharmaceutical substance in form of molecular inclusion complex in β-cyclodextrin by type "guest:host" in molar ratio of 1:1 chelate complex compound of manganese (II) with flavonoid of natural origin (+)-dihydroquercetin of general formula Met:L with stoichiometric ratio of 1:1 with content of Mn2+ ions 14%, where Met is manganese (II), L is deprotonated (+)-dihydroquercetin.
EFFECT: provided anti-tumour activity of injection solution prepared from powder.
1 cl, 3 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG WITH ANTITUMOR ACTIVITY AND METHOD OF ITS PREPARATION | 2023 |
|
RU2813724C1 |
| DIPROPIONATE BETULIN COMPOSITION | 2013 |
|
RU2541153C1 |
| BETULIN DIACETATE-BASED COMPOSITION | 2013 |
|
RU2517157C1 |
| SILVER NANOCOMPOSITE BASED ON ARABINOGALACTAN CONJUGATE AND FLAVONOIDS WITH ANTIMICROBIAL AND ANTITUMOR ACTION AND PREPARATION METHOD THEREOF | 2015 |
|
RU2611999C2 |
| AGENT WITH ANTITUMOR ACTIVITY BASED ON ARABINOGALACTAN NANOCOMPOSITES WITH SELENIUM AND METHODS FOR PREPARIATION OF SUCH NANOBIOCOMPOSITES | 2015 |
|
RU2614363C2 |
| ANTI-TUMOUR AGENT | 2013 |
|
RU2541130C1 |
| METHOD FOR PRODUCING MONO- AND BILIGAND COMPOUNDS OF BIVALENT METAL - ZINC, COPPER (II) AND CALCIUM IONS AND DIHYDROQUERCETIN POSSESSING IMPROVED ANTIOXIDANT ACTIVITY | 2013 |
|
RU2553428C2 |
| METHOD FOR TUMOUR GROWTH INHIBITION IN EXPERIMENT | 2015 |
|
RU2599438C1 |
| WATER-SOLUBLE MAGNETOACTIVE NANOBIOCOMPOSITES OF FLAVONOID COMPLEXES OF GADOLINIUM BASED ON A NATURAL CONJUGATE OF ARABINOGALACTAN WITH BIOFLAVONOIDS AND A METHOD OF PRODUCING SAID NANOBIOCOMPOSITES | 2019 |
|
RU2706705C1 |
| MEANS FOR TREATMENT OF MALIGNANT ASCITIC TUMOURS | 2011 |
|
RU2464974C1 |
